Gastrointestinal and Liver Manifestations of COVID-19
A novel Coronavirus, SARS-CoV-2 illness, has spread throughout the world after the first case was reported from Wuhan, China, in December 2019. This illness typically causes respiratory symptoms like fever, cough, and shortness of breath, although atypical presentation with gastrointestinal symptoms like abdominal pain, nausea, vomiting, or diarrhea are being increasingly reported. The viral RNA has been detected in saliva and stool of such patients, which raises concerns regarding the risk of transmission during gastrointestinal (GI) endoscopy. Many patients also have liver involvement, with the most common manifestation being deranged liver function tests. This review highlights the symptomatology, mechanism, and histopathology findings of SARS-CoV-2 in GI tract and liver. This review also focuses on implications of COVID-19 in patients afflicted with chronic liver disease and in patients undergoing liver transplantation.
30 June 2020 (online)
Thieme Medical and Scientific Publishers Private Ltd.
A-12, Second Floor, Sector -2, NOIDA -201301, India
- 1 Huang C, Wang Y, Li X. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395 (10223) 497-506
- 2 Lu R, Zhao X, Li J. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020; 395 (10224) 565-574
- 3 WHO. COVID-19 Dashboard. Available at: https://covid19.who.int. Accessed June 5, 2020
- 4 Guan WJ, Ni ZY, Hu Y. et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
- 5 Fang D, Ma J, Guan J. et al. Manifestations of digestive system in hospitalized patients with novel coronavirus pneumonia in Wuhan, China: a single-center, descriptive study. Chin J Dig 2020; DOI: 10.3760/cma.j.issn.0254-1432.2020.0005.
- 6 Wang D, Hu B, Hu C. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus–infected pneumonia in Wuhan, China. JAMA 2020; DOI: 10.1001/jama.2020.1585.
- 7 Sultan S, Altayar O, Siddique SM. et al. AGA. AGA Institute rapid review of the GI and liver manifestations of COVID-19, meta-analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology 2020; DOI: S0016-5085(20)30593-X.
- 8 Siegel A, Chang PJ, Jarou ZJ. et al. Lung Base findings of Coronavirus Disease (COVID-19) on abdominal CT in patients with predominant Gastrointestinal symptoms. Am J Roentgenol 2020; DOI: 10.2214/AJR.20.23232.
- 9 Luo S, Zhang X, Xu H. Don’t overlook digestive symptoms in patients with 2019 novel Coronavirus disease (COVID-19). Clin Gastroenterol Hepatol 2020; 18 (07) 1636-1637
- 10 Henry BM, de Oliveira MHS, Benoit J, Lippi G. Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID-19): a pooled analysis. Intern Emerg Med 2020; DOI: 10.1007/s11739-020-02329-9.
- 11 Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther 2020; 51 (09) 843-851
- 12 Nobel YR, Phipps M, Zucker J. et al. Gastrointestinal Symptoms and COVID-19: Case-Control Study from the United States. Gastroenterology 2020; DOI: 10.1053/j.gastro.2020.04.017.
- 13 Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol 2019; 17 (03) 181-192
- 14 Hoffmann M, Kleine-Weber H, Schroeder S. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 2020; DOI: 10.1016/j.cell.2020.02.052.
- 15 Hashimoto T, Perlot T, Rehman A. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 2012; 487 (7408) 477-481
- 16 Xiao F, Tang M, Zheng X, Liu Y, Li X, Shan H. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology 2020; DOI: 10.1053/j.gastro.2020.02.055.
- 17 Holshue ML, DeBolt C, Lindquist S. et al. Washington State 2019-nCoV Case Investigation Team. First case of 2019 Novel Coronavirus in the United States. N Engl J Med 2020; 382 (10) 929-936
- 18 To KK, Tsang OTY, Chik-Yan Yip C. et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis 2020; DOI: 10.1093/cid/ciaa149.
- 19 Liu Q, Wang R, Qu G. et al. Macroscopic autopsy findings in a patient with COVID-19. J Forensic Med 2020; 36: 1-3
- 20 National Health Commission of the People’s Republic of China. Guidance on coronavirus disease (COVID-19), China (Vision 7) (in Chinese). Available at: http://www.gov.cn/zhengce/zhengceku/2020-03/04/content_54867 05.htm. Accessed June 5, 2020
- 21 Barton LM, Duval EJ, Stroberg E, Ghosh S, Mukhopadhyay S. COVID-19 autopsies, Oklahoma, USA. Am J Clin Pathol 2020; 153 (06) 725-733
- 22 Qi X, Liu C, Jiang Z. et al. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury. J Hepatol 2020; DOI: 10.1016/j.jhep.2020.04.010.
- 23 Chen N, Zhou M, Dong X. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395 (10223) 507-513
- 24 Lei F, Liu YM, Zhou F. et al. Longitudinal association between markers of liver injury and mortality in COVID-19 in China. Hepatology 2020; DOI: 10.1002/hep.31301.
- 25 Jin X, Lian JS, Hu JH. et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020; 69 (06) 1002-1009
- 26 Weber S, Mayerle J, Irlbeck M, Gerbes AL. Severe liver failure during SARS-CoV-2 infection. Gut 2020; DOI: 10.1136/gutjnl-2020-321350.
- 27 Qiu H, Wander P, Bernstein D, Satapathy SK. Acute on chronic liver failure from novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Liver Int 2020; 00: 1-4
- 28 Große K, Kramer M, Trautwein C, Bruns T. SARS-CoV-2 as an extrahepatic precipitator of acute - on - chronic liver failure. Liver Int 2020; DOI: 10.1111/liv.14540.
- 29 Pirola CJ, Sookoian S. SARS-CoV-2 virus and liver expression of host receptors: putative mechanisms of liver involvement in COVID-19. Liver Int 2020; DOI: 10.1111/liv.14500.
- 30 Chai X, Hu L, Zhang Y. et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019;-nCoV infection. bioRxiv 2020; DOI: 10.1101/2020.02.03.931766.
- 31 Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020; 5 (05) 428-430
- 32 Puelles VG, Lütgehetmann M, Lindenmeyer MT. et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 2020; DOI: 10.1056/NEJMc2011400.
- 33 Wang Y, Liu S, Liu H. et al. SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19. J Hepatol 2020; DOI: 10.1016/j.jhep.2020.05.002.
- 34 Liu J, Li S, Liu J. et al. Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. medRxiv 2020; DOI: 10.1016/j.ebiom.2020.102763.
- 35 Lu L, Shuang L, Manman X. et al. Risk factors related to hepatic injury in patients with corona virus disease. medRxiv 2020; DOI: 10.1101/2020.02.28.20028514.
- 36 Bangash MN, Patel J, Parekh D. COVID-19 and the liver: little cause for concern. The Lancet Gastroenterology & Hepatology 2020; 5 (06) P529-530
- 37 Cai Q, Huang D, Yu H. COVID-19: Abnormal liver function tests. J Hepatol 2020; DOI: 10.1016/j.jhep.2020.04.006.
- 38 Xu Z, Shi L, Wang Y. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8 (04) 420-422
- 39 Tian S, Xiong Y, Liu H. et al. Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies. Mod Pathol 2020; DOI: 10.1038/s41379-020-0536-x.
- 40 Chen X, Jiang Q, Ma Z. et al. Clinical characteristics of hospitalized patients with SARS-CoV-2 and hepatitis B virus co-infection. medRxiv 2020; DOI: 10.1101/2020.03.23.20040733.
- 41 Surveillance Epidemiology of Coronavirus (COVID-19) Under Research Exclusion April 6, 2020
- 42 Singh S, Khan A. Clinical characteristics and outcomes of COVID-19 among patients with pre-existing liver disease in United States: a multi-center research network study. Gastroenterology 2020; DOI: 10.1053/j.gastro.2020.04.064.
- 43 Ji D, Qin E, Xu J. et al. Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study. J Hepatol 2020; DOI: 10.1016/j.jhep.2020.03.044.
- 44 Di Giorgio A, Nicastro E, Speziani C. et al. Health status of patients with autoimmune liver disease during SARS-CoV-2 outbreak in northern Italy. J Hepatol 2020; DOI: 10.1016/j.jhep.2020.05.008.
- 45 Angelico R, Trapani S, Manzia TM, Lombardini L, Tisone G, Cardillo M. The COVID-19 outbreak in Italy: initial implications for organ transplantation programs. Am J Transplant 2020; DOI: 10.1111/ajt.15904.
- 46 Agopian V, Verna E, Goldberg D. Changes in liver transplant center practice in response to COVID-19: Unmasking dramatic center-level variability. Liver Transpl 2020; DOI: 10.1002/lt.25789.
- 47 Lauterio A, De Carlis R, Belli L, Fumagalli R, De Carlis L. How to guarantee liver transplantation in the north of Italy during the COVID-19 pandemic: a sound transplant protection strategy. Transpl Int 2020; DOI: 10.1111/tri.13633.
- 48 National Transplant Specific Guidelines for COVID-19. 1754068/2020/NOTTO- DGHS; Annexure-A
- 49 Saigal S, Gupta S, Sudhindran S. et al. Liver transplantation and COVID-19 (Coronavirus) infection: guidelines of the Liver Transplant Society of India (LTSI).. Hepatol Int 2020; DOI: 10.1007/s12072-020-10041–1.
- 50 Qin J, Wang H, Qin X. et al. Perioperative presentation of COVID-19 disease in a liver transplant recipient. Hepatology 2020; DOI: 10.1002/hep.31257.
- 51 Huang JF, Zheng KI, George J. et al. Fatal outcome in a liver transplant recipient with COVID-19. Am J Transplant 2020; 00: 1-4
- 52 Philip M, Lakhtakia S, Aggarwal R, Madan K, Saraswat V, Makharia G. Joint guidance from SGEI, ISG and INASL for gastroenterologists and gastrointestinal endoscopists on the prevention, care, and management of patients with COVID-19. J Clin Exp Hepatol 2020; 10 (03) 266-270
- 53 Repici A, Aragona G, Cengia G. et al. ITALIAN GI-COVID19 Working Group. Low risk of covid-19 transmission in GI endoscopy. Gut 2020; 0: 1-3
- 54 Jiang X, Luo M, Zou Z. et al. Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days. J Med Virol 2020; DOI: 10.1002/jmv.25941.
- 55 Siew C, Ng, Francis KL, Chan, Paul KS. Chan. Screening FMT donors during the COVID-19 pandemic: a protocol for SARS-CoV-2 viral quantification. Lancet Gastroenterol Hepatol 2020; DOI: 10.1016/S2468-1253(20)30124-2.
- 56 Wu J, Liu J, Li S. et al. Detection and analysis of nucleic acid in various biological samples of COVID-19 patients. Travel Med Infect Dis 2020; DOI: 10.1016/j.tmaid.2020.101673.
- 57 Wu Y, Guo C, Tang L. et al. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol 2020; 5 (05) 434-435
- 58 Chen Y, Chen L, Deng Q. et al. The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients. J Med Virol 2020; DOI: 10.1002/jmv.25825.
- 59 Chen L, Lou J, Bai Y, Wang M. COVID-19 disease with positive fecal and negative pharyngeal and sputum viral tests. Am J Gastroenterol 2020; 115 (05) 790
- 60 Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect 2020;9(1):386-389
- 61 Yun H, Sun Z, Wu J, Tang A, Hu M, Xiang Z. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients. Clin Chim Acta 2020; 507: 94-97
- 62 Cheung KS, Hung IF, Chan PP. et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from the Hong Kong cohort and systematic review and meta-analysis. Gastroenterology 2020; DOI: 10.1053/j.gastro.2020.03.065.
- 63 Zhang J, Wang S, Xue Y. Fecal specimen diagnosis 2019 novel coronavirus-infected pneumonia. J Med Virol 2020; 92: 680-682
- 64 Wei X-S, Wang X, Niu Y-R. et al. Diarrhea is associated with prolonged symptoms and viral carriage in COVID-19. Clin Gastroenterol Hepatol 2020; DOI: 10.1016/j.cgh.2020.04.030.
- 65 Bhatraju PK, Ghassemieh BJ, Nichols M. et al. Covid-19 in critically ill patients in the Seattle region - Case Series. N Engl J Med 2020; 382 (21) 2012-2022
- 66 Xu X-W, Wu X–X, Jiang X-G, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ 2020. Doi: 10.1136/bmj.m792
- 67 Fan Z, Chen L, Li J, Cheng X, Jingmao Yang Tian C, Zhang Y. et al. Clinical Gastroenterology and Hepatology. Clinical features of COVID-19-related liver damage. 2020; 18 (07) 1561-1566
- 68 Cao B, Wang Y, Wn D. et al. A Trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020; 382: 1787-1799